Perfect Medical Health Management Limited (HKG:1830)
Hong Kong · Delayed Price · Currency is HKD 1.420
-0.015 (-1.05%)
Aug 12, 2026, 4:08 PM HKT
HKG:1830 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,784 | 1,407 | 2,852 | 4,020 | 4,963 | 6,014 | |
Market Cap Growth | -13.41% | -50.66% | -29.06% | -19.01% | -17.47% | 11.01% |
Enterprise Value | 1,627 | 1,162 | 2,609 | 3,608 | 4,579 | 5,708 |
Last Close Price | 1.42 | 1.12 | 2.08 | 2.60 | 2.96 | 3.46 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 10.00 | 7.87 | 13.78 | 12.73 | 15.73 | 19.70 |
Forward PE | - | 6.25 | 7.83 | 7.76 | 11.29 | 10.46 |
PS Ratio | 1.85 | 1.46 | 2.53 | 2.89 | 3.57 | 4.46 |
PB Ratio | 4.60 | 3.63 | 7.53 | 8.09 | 8.11 | 12.17 |
P/TBV Ratio | 4.58 | 3.61 | 7.51 | 8.08 | 8.11 | 12.17 |
P/FCF Ratio | 5.77 | 4.55 | 9.56 | 9.16 | 9.34 | 16.28 |
P/OCF Ratio | 5.25 | 4.14 | 8.57 | 8.09 | 8.85 | 11.70 |
PEG Ratio | - | 0.24 | 0.24 | 0.23 | 0.16 | 0.16 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.69 | 1.21 | 2.31 | 2.59 | 3.30 | 4.23 |
EV/EBITDA Ratio | 4.36 | 4.21 | 8.19 | 7.84 | 10.06 | 12.39 |
EV/EBIT Ratio | 7.39 | 5.28 | 10.40 | 9.46 | 12.42 | 14.87 |
EV/FCF Ratio | 5.26 | 3.76 | 8.75 | 8.22 | 8.62 | 15.45 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.35 | 0.35 | 0.57 | 0.54 | 0.39 | 0.63 |
Debt / EBITDA Ratio | 0.36 | 0.36 | 0.50 | 0.46 | 0.41 | 0.52 |
Debt / FCF Ratio | 0.44 | 0.44 | 0.73 | 0.61 | 0.45 | 0.84 |
Net Debt / Equity Ratio | -0.40 | -0.40 | -0.45 | -0.60 | -0.67 | -0.27 |
Net Debt / EBITDA Ratio | -0.56 | -0.56 | -0.53 | -0.65 | -0.90 | -0.29 |
Net Debt / FCF Ratio | -0.50 | -0.50 | -0.57 | -0.68 | -0.77 | -0.36 |
Asset Turnover | 1.09 | 1.09 | 1.05 | 1.11 | 1.08 | 0.98 |
Inventory Turnover | 36.94 | 36.94 | 41.82 | 65.03 | 68.07 | 101.72 |
Quick Ratio | 0.96 | 0.96 | 1.05 | 1.22 | 1.34 | 0.88 |
Current Ratio | 1.06 | 1.06 | 1.18 | 1.35 | 1.45 | 0.97 |
Return on Equity (ROE) | 46.53% | 46.53% | 47.14% | 55.97% | 57.05% | 51.78% |
Return on Assets (ROA) | 15.55% | 15.55% | 14.54% | 18.93% | 17.89% | 17.37% |
Return on Invested Capital (ROIC) | 79.78% | 84.21% | 100.82% | 153.72% | 105.50% | 77.84% |
Return on Capital Employed (ROCE) | 44.20% | 44.20% | 46.80% | 54.10% | 47.60% | 50.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 10.02% | 12.70% | 7.26% | 7.86% | 6.36% | 5.08% |
FCF Yield | 17.33% | 21.98% | 10.46% | 10.92% | 10.71% | 6.14% |
Dividend Yield | 10.17% | 13.04% | 7.93% | 9.64% | 8.55% | 7.18% |
Payout Ratio | 90.67% | 90.67% | 173.65% | 124.11% | 60.76% | 132.84% |
Buyback Yield / Dilution | - | - | 0.01% | -0.57% | -1.51% | -5.27% |
Total Shareholder Return | 9.93% | 13.04% | 7.94% | 9.07% | 7.04% | 1.90% |